To better understand the mechanism by which obesity and high blood cholesterol levels alter metabolic pathways in breast tumours and promote tumour growth, here, we investigated whether cholesterol, as an agonist of ERRα, promotes alteration in metabolic pathways in breast cancer cells via the ERRα axis. Here, ESRRA is linked to breast carcinoma.